Alpha 2.0
Login Register
» Articles » PMID: 34231527

Pancreatic Islets Quality and Potency Cannot Be Verified As Required for Drugs: Reflection on the FDA Review of a Biological License Application for Human Islets

Overview
Journal Transplantation
Specialty General Surgery
Date 2021 Jul 7
PMID 34231527
Citations 3
Authors
Piotr Witkowski
Roi Anteby
Oyedolamu K Olaitan
Racheal C Forbes
Silke Niederhaus
Camilo Ricordi
Jeffrey H Fair
Robert C Harland
Affiliations
Soon will be listed here.
Citing Articles

Demise of cadaveric islet transplantation in the USA: Quo Vadis, 1 year after BLA approval and 24 years after the Edmonton breakthrough?.

Witkowski P, Wojcik N, Appelbaum N, Fung J, Barth R, Ricordi C Front Transplant. 2025; 4:1491568.

PMID: 39949592 PMC: 11822476. DOI: 10.3389/frtra.2025.1491568.

Advances and challenges of the cell-based therapies among diabetic patients.

Raoufinia R, Rahimi H, Saburi E, Moghbeli M J Transl Med. 2024; 22(1):435.

PMID: 38720379 PMC: 11077715. DOI: 10.1186/s12967-024-05226-3.

Editorial: First Regulatory Approval for Allogeneic Pancreatic Islet Beta Cell Infusion for Adult Patients with Type 1 Diabetes Mellitus.

Parums D Med Sci Monit. 2023; 29:e941918.

PMID: 37525584 PMC: 10403990. DOI: 10.12659/MSM.941918.

Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress.

Witkowski P, Philipson L, Buse J, Robertson R, Alejandro R, Bellin M Front Endocrinol (Lausanne). 2022; 12:789526.

PMID: 35069442 PMC: 8772267. DOI: 10.3389/fendo.2021.789526.